Filing Flows › Biocryst Pharmaceuticals (BCRX) › Who owns the stock
Who owns Biocryst Pharmaceuticals (BCRX) stock
298 funds reported Biocryst Pharmaceuticals (BCRX) shares in their latest 13F filings, worth $2.8B in all. The largest holder is BlackRock ($239M). Last quarter 169 funds added to their stakes and 112 cut them. Members of Congress and other officials disclosed 2 trades (2 buys, 0 sales).
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| BlackRock | 23,893,036 | $239M | increase | 2026-06-30 |
| Vanguard Group | 22,273,375 | $174M | increase | 2025-12-31 |
| RA Capital Management, L.P. | 15,827,186 | $158M | unchanged | 2026-06-30 |
| State Street | 15,191,098 | $152M | increase | 2026-06-30 |
| Deerfield Management Company, L.P. (series C) | 15,096,403 | $151M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 11,364,236 | $114M | increase | 2026-06-30 |
| Vanguard Portfolio Management LLC | 11,139,158 | $111M | decrease | 2026-06-30 |
| TCG Crossover Management, LLC | 11,020,968 | $110M | unchanged | 2026-06-30 |
| Perceptive Advisors LLC | 10,308,888 | $103M | increase | 2026-06-30 |
| Jupiter Topco LLC | 9,540,764 | $95.3M | base | 2026-06-30 |
| Janus Henderson Group | 8,908,506 | $84.9M | increase | 2026-03-31 |
| Vestal Point Capital, LP | 8,300,000 | $83.0M | increase | 2026-06-30 |
| Two Sigma Investments, LP | 6,775,349 | $67.8M | increase | 2026-06-30 |
| Geode Capital Management, LLC | 6,248,046 | $62.5M | increase | 2026-06-30 |
| abrdn | 5,310,871 | $53.1M | increase | 2026-06-30 |
Trades by Congress and other officials
| Date | Who | Trade | Amount |
|---|---|---|---|
| 2026-07-10 | Gilbert Cisneros | purchase | $1K–$15K |
| 2025-11-13 | Gilbert Cisneros | purchase | $1K–$15K |
Biocryst Pharmaceuticals' latest quarter
Biocryst Pharmaceuticals, Q3 2026: revenue $180M (+13% year over year), operating margin 29.6%, net earnings $37.9M, operating cash flow $33.0M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most BCRX stock?
By the latest 13F filings: BlackRock ($239M); Vanguard Group ($174M); RA Capital Management, L.P. ($158M); State Street ($152M); Deerfield Management Company, L.P. (series C) ($151M).
Has Congress traded BCRX stock?
Officials disclosed 2 trades on file: 2 buys and 0 sales. The latest: Gilbert Cisneros, purchase on 2026-07-10.
What is the short interest in BCRX?
26,597,263 shares were sold short at the 2026-10-15 settlement, -3.26% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.